4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-056792
Director sold 18,650 shares at an average $552.15 ($10,297,573)
- Director acquired 18,650 shares (option exercise)
- Director gave 5,455 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2025-12-10 | Option exercise 10b5-1 | +18,650 | $15.80 | $294,670 | 479,694 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −491 | $547.76 | $268,949 | 479,203 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −369 | $548.56 | $202,418 | 478,834 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −486 | $550.07 | $267,335 | 478,348 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −4,723 | $550.99 | $2,602,307 | 473,625 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −4,410 | $551.85 | $2,433,641 | 469,215 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −3,857 | $552.81 | $2,132,197 | 465,358 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −3,087 | $553.88 | $1,709,826 | 462,271 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −1,027 | $554.84 | $569,822 | 461,244 | D |
| Taub Rebecca Director | 2025-12-10 | Sale 10b5-1 | −200 | $555.39 | $111,078 | 461,044 | D |
| Taub Rebecca Director | 2025-12-10 | Gift 10b5-1 | −5,455 | 455,589 | D | ||
| Derivatives | |||||||
| Taub Rebecca Director | 2025-12-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,650 | 18,650 | D | ||
| Open-market sales · 18,650 sh · avg $552.15 · $10,297,573 | |||||||
Loading xslF345X05/wk-form4_1765575309.xml…